 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Eli Lilly and stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:LLY! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Eli Lilly and stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Average volume
5.59 million shs
MARKET CAP
$195.43 billion
Stock exchange
NYSE
Buy this stock!
- Stephen Johnson
- April 25, 2021
- No Comments
How to buy Eli Lilly and stocks?
Below is a quick guide on how to buy NYSE:LLY stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Eli Lilly and shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Eli Lilly and – Search for “”NYSE:LLY”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Eli Lilly and stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Is Eli Lilly and a buy right now?
15 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Eli Lilly and in the last year. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should “buy” Eli Lilly and stock.
What stocks does BAMagazine like better than Eli Lilly and?
Wall Street analysts have given Eli Lilly and a “Buy” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Eli Lilly and wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
How to buy Eli Lilly and stocks step by step guide
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:LLY stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Eli Lilly and stocks with a step by step approach.
Step 1: Open an Account with a Broker
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Eli Lilly and stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Step 2: Verify your Account
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Step 3: Fund your eToro Account
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Step 4: Search for Eli Lilly and stocks
Now that you’ve funded your eToro account, just type “NYSE:LLY stocks” into the search bar at the top of the screen and press “trade”.
Step 5: Buy NYSE:LLY
All that’s left is to buy some NYSE:LLY stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
How And Where To Buy Stocks Conclusion
All in all, NYSE:LLY is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Eli Lilly and stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
When is Eli Lilly and’s next earnings date?
Eli Lilly and is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for Eli Lilly and.
How were Eli Lilly and’s earnings last quarter?
Eli Lilly and Company (NYSE:LLY) posted its earnings results on Thursday, January, 28th. The company reported $2.75 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.35 by $0.40. The company earned $7.44 billion during the quarter, compared to the consensus estimate of $7.27 billion. Eli Lilly and had a net margin of 24.01% and a trailing twelve-month return on equity of 166.45%. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.73 EPS.
View Eli Lilly and’s earnings history.
How has Eli Lilly and’s stock been impacted by Coronavirus?
Eli Lilly and’s stock was trading at $140.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LLY shares have increased by 44.8% and is now trading at $202.69.
How often does Eli Lilly and pay dividends? What is the dividend yield for Eli Lilly and?
Eli Lilly and declared a quarterly dividend on Monday, December 14th. Investors of record on Friday, February 12th will be paid a dividend of $0.85 per share on Wednesday, March 10th. This represents a $3.40 annualized dividend and a yield of 1.68%. The ex-dividend date is Thursday, February 11th. This is a positive change from Eli Lilly and’s previous quarterly dividend of $0.74.
View Eli Lilly and’s dividend history.
Where to Buy Eli Lilly and Stocks Broker Reviews
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:LLY stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
- eToro takes pride in keeping their customers safe, they follow strict data protection rules to keep access to sensitive information to a minimum. Any of the information you provide eToro is even protected by SSL encryption, this ensures that even if someone were to gain access to the servers all your data remains safe.
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
Excellent for both new and experienced traders
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Is Eli Lilly and a good dividend stock?
Eli Lilly and pays an annual dividend of $2.96 per share and currently has a dividend yield of 1.47%. Eli Lilly and does not yet have a strock track record of dividend growth. The dividend payout ratio of Eli Lilly and is 49.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Eli Lilly and will have a dividend payout ratio of 37.09% next year. This indicates that Eli Lilly and will be able to sustain or increase its dividend.
View Eli Lilly and’s dividend history.
What guidance has Eli Lilly and issued on next quarter’s earnings?
Eli Lilly and updated its FY21 earnings guidance on Friday, January, 29th. The company provided earnings per share (EPS) guidance of $7.75-8.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.19. The company issued revenue guidance of $26.5-28.0 billion, compared to the consensus revenue estimate of $27.60 billion.
Compliance
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
What price target have analysts set for LLY?
15 equities research analysts have issued 12 month price objectives for Eli Lilly and’s stock. Their forecasts range from $144.00 to $232.00. On average, they anticipate Eli Lilly and’s share price to reach $187.60 in the next year. This suggests that the stock has a possible downside of 7.4%.
View analysts’ price targets for Eli Lilly and or view top-rated stocks among Wall Street analysts.
Are investors shorting Eli Lilly and?
Eli Lilly and saw a increase in short interest in December. As of December 31st, there was short interest totaling 6,890,000 shares, an increase of 24.1% from the December 15th total of 5,550,000 shares. Based on an average trading volume of 4,150,000 shares, the short-interest ratio is currently 1.7 days. Approximately 0.9% of the company’s stock are sold short.
View Eli Lilly and’s Short Interest.
Who are Eli Lilly and’s key executives?
Eli Lilly and’s management team includes the following people:
Mr. David A. Ricks, Chairman, CEO & Pres (Age 53, Pay $4.4M)
Mr. Joshua L. Smiley, Sr. VP & CFO (Age 51, Pay $2.13M)
Dr. Daniel M. Skovronsky, Sr. VP, Chief Scientific Officer & Pres of Lilly Research Labs (Age 48, Pay $2.14M)
Mr. Jacob S. Van Naarden, Chief Operating Officer of Loxo Oncology (Age 36)
Mr. Donald A. Zakrowski, Chief Accounting Officer & VP of Fin.
Mr. Martin Bott MIBS, VP of Fin. & Special Projects (Age 58)
Ms. Aarti Shreyas Shah Ph.D., Sr. VP & Chief Information and Digital Officer (Age 57)
Kevin Hern, VP of Investor Relations
Ms. Melissa Stapleton Barnes, Sr. VP of Enterprise Risk Management and Chief Ethics & Compliance Officer (Age 53)
Ms. Anat Hakim J.D., Sr. VP, Gen. Counsel & Sec. (Age 52)
What is David A. Ricks’ approval rating as Eli Lilly and’s CEO?
399 employees have rated Eli Lilly and CEO David A. Ricks on Glassdoor.com. David A. Ricks has an approval rating of 86% among Eli Lilly and’s employees.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Who are some of Eli Lilly and’s key competitors?
Some companies that are related to Eli Lilly and include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of LLY’s competitors.
What other stocks do shareholders of Eli Lilly and own?
Based on aggregate information from BAMagazine watchlists, some companies that other Eli Lilly and investors own include Johnson & Johnson (JNJ), Pfizer (PFE), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Bristol-Myers Squibb (BMY), The Walt Disney (DIS), AT&T (T), Verizon Communications (VZ) and JPMorgan Chase & Co. (JPM).
What is Eli Lilly and’s stock symbol?
Eli Lilly and trades on the New York Stock Exchange (NYSE) under the ticker symbol “LLY.”
Who are Eli Lilly and’s major shareholders?
Eli Lilly and’s stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (6.15%), Fisher Asset Management LLC (0.53%), California Public Employees Retirement System (0.48%), Swiss National Bank (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.33%) and Robeco Institutional Asset Management B.V. (0.28%). Company insiders that own Eli Lilly and stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, David A Ricks, Donald A Zakrowski, Enrique A Conterno, Jackson P Tai, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O’neill and Stephen F Fry.
View institutional ownership trends for Eli Lilly and.
Which institutional investors are selling Eli Lilly and stock?
LLY stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, BlackRock Inc., AJO LP, Victory Capital Management Inc., Sumitomo Mitsui Trust Holdings Inc., NN Investment Partners Holdings N.V., PGGM Investments, and Nisa Investment Advisors LLC. Company insiders that have sold Eli Lilly and company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Lilly Endowment Inc, Melissa S Barnes, Myles O’neill, and Stephen F Fry.
View insider buying and selling activity for Eli Lilly and or view top insider-selling stocks.
Which institutional investors are buying Eli Lilly and stock?
LLY stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Assenagon Asset Management S.A., Strs Ohio, State of Wisconsin Investment Board, First Trust Advisors LP, Cadinha & Co. LLC, California Public Employees Retirement System, and Crossmark Global Holdings Inc.. Company insiders that have bought Eli Lilly and stock in the last two years include Anne E White, David A Ricks, Jackson P Tai, and Joshua L Smiley.
View insider buying and selling activity for Eli Lilly and or or view top insider-buying stocks.
More information
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
Frequently asked questions
How to buy Eli Lilly and stocks?
The safest and easiest way to buy NYSE:LLY stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Eli Lilly and stock?
You will first want to find a licensed broker that supports Eli Lilly and stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:LLY stocks in a safe and complete environment.
Is NYSE:LLY stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:LLY stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Eli Lilly and stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:LLY is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Eli Lilly and stock.
How do you trade Eli Lilly and stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Eli Lilly and stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:LLY stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Eli Lilly and stock?
To sell your NYSE:LLY stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Eli Lilly and stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:LLY stock.
Share this information
Share on facebook
Facebook
Share on twitter
Twitter
Stephen Johnson
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
Table of Contents
| |
Our score |
0% commission |
Other stocks
Related News
December 15, 2021
No Comments
English 
Svenska 
Dansk 
Nederlands 
Suomi 
Eesti 
日本語